Dosage of Madopar-F in details
Madopar-F Dosage
Generic name: Madopar-F 42mg
Dosage form: capsule
Medically reviewed on January 3, 2019.
Madopar-F capsules are for oral inhalation only and should be used only with the Madopar-F inhaler.
Important Administration Instructions
Madopar-F capsules are for oral inhalation only and should be used only with the Madopar-F inhaler. Madopar-F capsules must not be swallowed as the intended effect will not be obtained. Madopar-F capsules should be stored in their blister package and only removed immediately before use.
Recommended Dosage
Madopar-F should be taken when symptoms of an OFF period start to return.
The recommended dosage of Madopar-F is oral inhalation of the contents of two 42 mg capsules (84 mg) as needed, up to 5 times a day. The maximum dose per OFF period is 84 mg, and the maximum daily dosage is 420 mg. Madopar-F has been shown to be effective only in combination with carbidopa/Madopar-F.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Medical Disclaimer
More about Madopar-F (Madopar-F)
- Madopar-F Side Effects
- During Pregnancy or Breastfeeding
- Drug Interactions
- Drug class: dopaminergic antiparkinsonism agents
Professional resources
- Madopar-F (FDA)
Related treatment guides
- Parkinson's Disease
What other drugs will affect Madopar-F?
Using Madopar-F with other drugs that make you drowsy can worsen this effect. Ask your doctor before using opioid medication, a sleeping pill, a muscle relaxer, or medicine for anxiety or seizures.
Tell your doctor about all your other medicines, especially:
-
isoniazid;
-
metoclopramide;
-
risperidone or other antipsychotic medication;
-
iron medication, such as ferrous fumarate, ferrous gluconate, or ferrous sulfate;
-
a multivitamin or mineral supplement that contains iron; or
-
other medicines to treat Parkinson's disease.
This list is not complete. Other drugs may interact with Madopar-F, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.
Madopar-F drug interactions (more detail)
Madopar-F interactions
Increased postural hypotension and possible reduced absorption with TCAs. Reduced effects with phenothiazines, butyrophenones, thioxanthenes and other antipsychotic agents; reserpine, papaverine, phenytoin, isoniazid. Reversal of effects of Madopar-F monotherapy with pyridoxine. Exacerbation of abnormal involuntary movements and possibly delayed absorption with anticholinergics. Additive hypotensive effects with antihypertensive agents. Increased CNS toxicity with methyldopa. Exacerbation of parkinsonian symptoms with metoclopramide.
Potentially Fatal: Increased risk of hypertensive crises with nonselective MAOIs. Increased risk of cardiac arrhythmias with cyclopropane or halogenated anaesthetics.
References
- DailyMed. "CARBIDOPA; ENTACAPONE; LEVODOPA: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
- FDA/SPL Indexing Data. "46627O600J: The UNique Ingredient Identifier (UNII) is an alphanumeric substance identifier from the joint FDA/USP Substance Registration System (SRS).". https://www.fda.gov/ForIndustry/Data... (accessed September 17, 2018).
- MeSH. "Dopamine Agents". https://www.ncbi.nlm.nih.gov/mesh/68... (accessed September 17, 2018).
Reviews
The results of a survey conducted on ndrugs.com for Madopar-F are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Madopar-F. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.User reports
Consumer reported frequency of use
No survey data has been collected yetConsumer reported doses
No survey data has been collected yetConsumer reviews
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology